These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34797640)

  • 1. Evaluation of a Three-Dimensional Primary Human Hepatocyte Spheroid Model: Adoption and Industrialization for the Enhanced Detection of Drug-Induced Liver Injury.
    Schofield CA; Walker TM; Taylor MA; Patel M; Vlachou DF; Macina JM; Vidgeon-Hart MP; Williams A; McGill PJ; Newman CF; Sakatis MZ
    Chem Res Toxicol; 2021 Dec; 34(12):2485-2499. PubMed ID: 34797640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput confocal imaging of differentiated 3D liver-like spheroid cellular stress response reporters for identification of drug-induced liver injury liability.
    Hiemstra S; Ramaiahgari SC; Wink S; Callegaro G; Coonen M; Meerman J; Jennen D; van den Nieuwendijk K; Dankers A; Snoeys J; de Bont H; Price L; van de Water B
    Arch Toxicol; 2019 Oct; 93(10):2895-2911. PubMed ID: 31552476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined Conditions.
    Vorrink SU; Zhou Y; Ingelman-Sundberg M; Lauschke VM
    Toxicol Sci; 2018 Jun; 163(2):655-665. PubMed ID: 29590495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study.
    Bell CC; Dankers ACA; Lauschke VM; Sison-Young R; Jenkins R; Rowe C; Goldring CE; Park K; Regan SL; Walker T; Schofield C; Baze A; Foster AJ; Williams DP; van de Ven AWM; Jacobs F; Houdt JV; Lähteenmäki T; Snoeys J; Juhila S; Richert L; Ingelman-Sundberg M
    Toxicol Sci; 2018 Apr; 162(2):655-666. PubMed ID: 29329425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 3D spheroid model of quadruple cell co-culture with improved liver functions for hepatotoxicity prediction.
    Sun B; Liang Z; Wang Y; Yu Y; Zhou X; Geng X; Li B
    Toxicology; 2024 Jun; 505():153829. PubMed ID: 38740170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HepaRG culture in tethered spheroids as an in vitro three-dimensional model for drug safety screening.
    Wang Z; Luo X; Anene-Nzelu C; Yu Y; Hong X; Singh NH; Xia L; Liu S; Yu H
    J Appl Toxicol; 2015 Aug; 35(8):909-17. PubMed ID: 25512232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic responses of HepG2 cell monolayers and 3D spheroids to selected hepatotoxins.
    Hurrell T; Lilley KS; Cromarty AD
    Toxicol Lett; 2019 Jan; 300():40-50. PubMed ID: 30381255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening.
    Wang Z; Li W; Jing H; Ding M; Fu G; Yuan T; Huang W; Dai M; Tang D; Zeng M; Chen Y; Zhang H; Zhu X; Peng Y; Li Q; Yu WF; Yan HX; Zhai B
    Theranostics; 2019; 9(22):6690-6705. PubMed ID: 31588244
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhanced hepatotoxicity assessment through encapsulated HepG2 spheroids in gelatin hydrogel matrices: Bridging the gap from 2D to 3D culture.
    Park SY; Koh WG; Lee HJ
    Eur J Pharm Biopharm; 2024 Sep; 202():114417. PubMed ID: 39013493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sub-chronic Xysmalobium undulatum hepatotoxicity investigation in HepG2/C3A spheroid cultures compared to an in vivo model.
    Calitz C; Hamman JH; Fey SJ; Viljoen AM; Gouws C; Wrzesinski K
    J Ethnopharmacol; 2019 Jul; 239():111897. PubMed ID: 31009705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease.
    Bell CC; Hendriks DF; Moro SM; Ellis E; Walsh J; Renblom A; Fredriksson Puigvert L; Dankers AC; Jacobs F; Snoeys J; Sison-Young RL; Jenkins RE; Nordling Å; Mkrtchian S; Park BK; Kitteringham NR; Goldring CE; Lauschke VM; Ingelman-Sundberg M
    Sci Rep; 2016 May; 6():25187. PubMed ID: 27143246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical-based primary human hepatocyte monolayer culture for the study of drug metabolism and hepatotoxicity: Comparison with the spheroid model.
    Zhong Y; Yu JS; Wang X; Binas B; Yoo HH
    FASEB J; 2021 Mar; 35(3):e21379. PubMed ID: 33566373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid.
    Foster AJ; Chouhan B; Regan SL; Rollison H; Amberntsson S; Andersson LC; Srivastava A; Darnell M; Cairns J; Lazic SE; Jang KJ; Petropolis DB; Kodella K; Rubins JE; Williams D; Hamilton GA; Ewart L; Morgan P
    Arch Toxicol; 2019 Apr; 93(4):1021-1037. PubMed ID: 30915487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tethered spheroids as an in vitro hepatocyte model for drug safety screening.
    Xia L; Sakban RB; Qu Y; Hong X; Zhang W; Nugraha B; Tong WH; Ananthanarayanan A; Zheng B; Chau IY; Jia R; McMillian M; Silva J; Dallas S; Yu H
    Biomaterials; 2012 Mar; 33(7):2165-76. PubMed ID: 22189144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated biomimetic array chip for establishment of collagen-based 3D primary human hepatocyte model for prediction of clinical drug-induced liver injury.
    Xiao RR; Lv T; Tu X; Li P; Wang T; Dong H; Tu P; Ai X
    Biotechnol Bioeng; 2021 Dec; 118(12):4687-4698. PubMed ID: 34478150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tethered primary hepatocyte spheroids on polystyrene multi-well plates for high-throughput drug safety testing.
    Tasnim F; Singh NH; Tan EKF; Xing J; Li H; Hissette S; Manesh S; Fulwood J; Gupta K; Ng CW; Xu S; Hill J; Yu H
    Sci Rep; 2020 Mar; 10(1):4768. PubMed ID: 32179810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity.
    Meng Q
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):733-46. PubMed ID: 20380484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis.
    Sirenko O; Hancock MK; Hesley J; Hong D; Cohen A; Gentry J; Carlson CB; Mann DA
    Assay Drug Dev Technol; 2016 Sep; 14(7):381-94. PubMed ID: 27494736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent.
    Parmentier C; Hendriks DFG; Heyd B; Bachellier P; Ingelman-Sundberg M; Richert L
    Toxicol Lett; 2018 Oct; 295():187-194. PubMed ID: 29913214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary-like human hepatocytes genetically engineered to obtain proliferation competence display hepatic differentiation characteristics in monolayer and organotypical spheroid cultures.
    Herzog N; Hansen M; Miethbauer S; Schmidtke KU; Anderer U; Lupp A; Sperling S; Seehofer D; Damm G; Scheibner K; Küpper JH
    Cell Biol Int; 2016 Mar; 40(3):341-53. PubMed ID: 26715207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.